Savara Inc Marketable Securities, Unrealized Gain (Loss)
Savara Inc (SVRA) reported Marketable Securities, Unrealized Gain (Loss) of $1.00 thousand for the 12-month period ending 2016-12-31, per its 10-Q filed 2017-05-09.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2017-05-09
- Savara Inc marketable securities, unrealized gain (loss) for the quarter ending 2016-12-31 was -$3.00K.
- Savara Inc marketable securities, unrealized gain (loss) for the quarter ending 2016-09-30 was -$3.00K.
- Savara Inc marketable securities, unrealized gain (loss) for the quarter ending 2016-06-30 was $2.00K, a 71.43% decline year-over-year.
- Savara Inc marketable securities, unrealized gain (loss) for the quarter ending 2016-03-31 was $5.00K, a 150.00% increase year-over-year.
- Savara Inc marketable securities, unrealized gain (loss) for fiscal 2015 was -$17.00K.
- Savara Inc marketable securities, unrealized gain (loss) for fiscal 2014 was -$25.00K, a 231.58% decline from fiscal 2013.
- Savara Inc marketable securities, unrealized gain (loss) for fiscal 2013 was $19.00K, a 49900.00% increase from fiscal 2012.
- Savara Inc marketable securities, unrealized gain (loss) for fiscal 2012 was $38.00.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month | Marketable Securities, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | -$3.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2017-05-09 | -$6.00K derived: sum of 2 quarters · filed 2017-05-09 | -$4.00K derived: sum of 3 quarters · filed 2017-05-09 | $1.00K 10-Q · filed 2017-05-09 | |
| 2016-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$1.00K derived: sum of 2 quarters · filed 2016-11-08 | $4.00K 10-Q · filed 2016-11-08 | -$22.00K derived: sum of 4 quarters · filed 2017-03-06 | |
| 2016-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $7.00K 10-Q · filed 2016-08-09 | -$19.00K derived: sum of 3 quarters · filed 2017-03-06 | -$19.00K derived: sum of 4 quarters · filed 2017-03-06 | |
| 2016-03-31 | $5.00K 10-Q · filed 2016-05-06 | -$21.00K derived: sum of 2 quarters · filed 2017-03-06 | -$21.00K derived: sum of 3 quarters · filed 2017-03-06 | -$14.00K derived: sum of 4 quarters · filed 2017-03-06 | |
| 2015-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$26.00K derived: sum of 2 quarters · filed 2017-03-06 | -$19.00K derived: sum of 3 quarters · filed 2017-03-06 | -$17.00K 10-K · filed 2017-03-06 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $7.00K derived: sum of 2 quarters · filed 2015-11-12 | $9.00K 10-Q · filed 2015-11-12 | $6.52K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2015-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $9.00K 10-Q · filed 2015-08-12 | $6.52K derived: sum of 3 quarters · filed 2016-03-14 | -$243.00 derived: sum of 4 quarters · filed 2016-03-14 | |
| 2015-03-31 | $2.00K 10-Q · filed 2015-05-11 | -$479.00 derived: sum of 2 quarters · filed 2016-03-14 | -$7.24K derived: sum of 3 quarters · filed 2016-03-14 | $1.03K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-12-31 | -$2.48K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$9.24K derived: sum of 2 quarters · filed 2016-03-14 | -$971.00 derived: sum of 3 quarters · filed 2016-03-14 | -$25.00K 10-K · filed 2016-03-14 | $25.00K 10-K · filed 2015-03-24 |
| 2014-09-30 | -$6.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $1.51K derived: sum of 2 quarters · filed 2014-10-31 | -$22.52K 10-Q · filed 2014-10-31 | $22.89K derived: sum of 4 quarters · filed 2015-03-24 | |
| 2014-06-30 | $8.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$15.76K 10-Q · filed 2014-08-11 | $29.66K derived: sum of 3 quarters · filed 2015-03-24 | -$3.44K derived: sum of 4 quarters · filed 2015-03-24 | |
| 2014-03-31 | -$24.03K 10-Q · filed 2014-05-05 | $21.39K derived: sum of 2 quarters · filed 2015-03-24 | -$11.71K derived: sum of 3 quarters · filed 2015-03-24 | -$13.52K derived: sum of 4 quarters · filed 2015-03-24 | |
| 2013-12-31 | $45.41K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | $12.32K derived: sum of 2 quarters · filed 2015-03-24 | $10.51K derived: sum of 3 quarters · filed 2015-03-24 | $19.00K 10-K · filed 2015-03-24 | -$18.58K 10-K · filed 2014-03-26 |
| 2013-09-30 | -$33.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | -$34.90K derived: sum of 2 quarters · filed 2013-11-04 | -$26.41K 10-Q · filed 2013-11-04 | -$26.45K derived: sum of 4 quarters · filed 2013-11-04 | |
| 2013-06-30 | -$1.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $6.68K 10-Q · filed 2013-08-05 | $6.64K derived: sum of 3 quarters · filed 2013-08-05 | $6.72K derived: sum of 4 quarters · filed 2013-08-05 | |
| 2013-03-31 | $8.49K 10-Q · filed 2013-05-15 | $8.45K derived: sum of 2 quarters · filed 2013-05-15 | $8.52K derived: sum of 3 quarters · filed 2013-05-15 | ||
| 2012-12-31 | -$41.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-19 | $35.00 derived: sum of 2 quarters · filed 2013-03-19 | $38.00 10-K · filed 2013-03-19 | ||
| 2012-09-30 | $76.00 10-Q · filed 2012-11-05 | $79.00 10-Q · filed 2012-11-05 | |||
| 2012-06-30 | $139.00 10-Q · filed 2012-08-06 | ||||
| 2011-09-30 | $25.00 10-Q · filed 2012-11-05 | $25.00 10-Q · filed 2012-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |